Cara Therapeutics | Aktywa





Aktywa Zmiana Data
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Assertio Holdings USD 263.57M 53.36M 2025-09
Cara Therapeutics USD 43.13M 4.18M 2025-06
Cassava Sciences USD 108.91M 5.91M 2025-09
Chugai Pharma JPY 1.74T 223.03B 2025-12
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 88.92M 8.72M 2025-09
CSL USD 11.85B 542M 2025-06
Grifols EUR 6.28B 92.48M 2025-09
Halozyme Therapeutics USD 1.33B 206.08M 2025-09
J&J USD 54.61B 113M 2025-09
Neurocrine Biosciences USD 2.16B 409.5M 2025-09
Pacira USD 562.75M 182.86M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
RedHill Biopharma USD 12.56M 644K 2025-06
Supernus Pharmaceuticals USD 593.89M 144.98M 2025-09
Vanda Pharmaceuticals USD 367.5M 27.42M 2025-09


Cara Therapeutics Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.